CNS Pharmaceuticals, Inc. (CNSP) stock
CNSPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.15+0.67 (+19.25%)
Close on Nov 17, 2026Market cap $6.07MP/E –Yield –
CNS Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
CNS Pharmaceuticals's price to book ratio was 0.3× on Nov 11, 2026, against 0.4× a year earlier. Over the last 3 years it ranged from 0.2× to 481.3×, with a median of 2.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.3× | −0.0 |
| 2025 | Dec 31, 2025 | 0.3× | −179.9 |
| 2023 | Apr 28, 2023 | 180.2× | −73.8 |
| 2022 | Dec 30, 2022 | 253.9× | – |
See a number that looks wrong?